Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are the most effective antiinflammatory agents for the treatment of chronic inflammatory diseases even though some diseases, such as chronic obstructive pulmonary disease (COPD), are relatively glucocorticoid insensitive. However, the molecular mechanism of this glucocorticoid insensitivity remains uncertain. We show that a defect of glucocorticoid receptor (GR) deacetylation caused by impaired histone deacetylase (HDAC) 2 induces glucocorticoid insensitivity toward nuclear factor (NF)-kappaB-mediated gene expression. Specific knockdown of HDAC2 by RNA interference resulted in reduced sensitivity to dexamethasone suppression of interleukin 1beta-induced granulocyte/macrophage colony-stimulating factor production. Loss of HDAC2 did not reduce GR nuclear translocation, GR binding to glucocorticoid response element (GRE) on DNA, or GR-induced DNA or gene induction but inhibited the association between GR and NF-kappaB. GR becomes acetylated after ligand binding, and HDAC2-mediated GR deacetylation enables GR binding to the NF-kappaB complex. Site-directed mutagenesis of K494 and K495 reduced GR acetylation, and the ability to repress NF-kappaB-dependent gene expression becomes insensitive to histone deacetylase inhibition. In conclusion, we show that overexpression of HDAC2 in glucocorticoid-insensitive alveolar macrophages from patients with COPD is able to restore glucocorticoid sensitivity. Thus, reduction of HDAC2 plays a critical role in glucocorticoid insensitivity in repressing NF-kappaB-mediated, but not GRE-mediated, gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have shown that acetylation of GR by clock transcription factor reduces GR transcriptional activity82, 83.”
From Corticosteroids (2016) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968 · cited 2×
“In previous studies, we have found that total nuclear HDAC activity and HDAC2 expression are decreased in lung macrophages and peripheral lung tissue obtained from chronic obstructive pulmonary disease (COPD) (6, 7) and that the reduction correlates with disease severity.”
BackgroundSelf-citationIto, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723 · cited 7×
“A similar result was seen after treatment with TSA (19).”
BackgroundMethodResultInfluentialSelf-citationHistone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700 · cited 1×
“At least 18 HDACs are now recognized in mammalian cells (4, 5) and are grouped into 4 classes based on similarity of genes in yeast.”
BackgroundMolecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · cited 1×
“also show that the GR represses a large set of functionally related infl ammatory response genes by disrupting p65–interferon regulatory factor complexes (12).”
BackgroundNissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559 · cited 1×
“1 C) and suggests that, at these supraphysiological concentrations, alternative mechanisms of action may be occurring (20).”
BackgroundITO, K., LIM, S., CARAMORI, G., CHUNG, K. F., BARNES, P. J., & ADCOCK, I. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0432fje · Cited by 481 · cited 3×
“In addition, there is a negative correlation between the repressive eff ect of Dex on cytokine production and total HDAC activity in alveolar macrophages from smokers and nonsmokers (16).”
BackgroundSelf-citationTheophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473 · cited 2×
“In previous studies, we have found that total nuclear HDAC activity and HDAC2 expression are decreased in lung macrophages and peripheral lung tissue obtained from chronic obstructive pulmonary disease (COPD) (6, 7) and that the reduction correlates with disease severity.”
BackgroundSelf-citationLasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382 · cited 1×
“Within the nucleus, GR either induces transcription of genes, such as secretary leukocyte proteinase inhibitor (SLPI) (8) and mitogen-activated kinase phosphatase–1 (9), or inhibits expression of genes such as IL-6 (10) by binding to specifi c DNA elements (glucocorticoid response elements [GREs]) at the promoter/enha…”
BackgroundWang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366 · cited 1×
“GR is an acetylated protein and deacetylated by HDAC2 Previous studies have shown that both estrogen receptor α and androgen receptor are acetylated within their hinge/ ligand binding domains and that this can modulate hormoneinduced gene induction (21, 22).”
Background
Cited by
Items 301–400 of 646
Inhibited proliferation of human lung fibroblasts by LPS is through IL-6 and IL-8 release
Zhang, J., Wu, L., & Qu, J. (2011) · Cytokine · doi:10.1016/j.cyto.2011.02.018 · Cited by 33
Lovén, J., Svitacheva, N., Jerre, A., Miller‐Larsson, A., & Korn, S. H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00129606 · Cited by 35
“This would fit well with the findings of ITO et al. [ 31 ], which demonstrate a better anti-inflammatory efficacy when the GR is in a deacetylated form.”
ResultOjo, O. O., Lagan, A. L., Rajendran, V., Spanjer, A. I. R., Chen, L., Sohal, S. S., Heijink, I. H., Jones, R., Maarsingh, H., & Hackett, T. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.04.004 · Cited by 35
Huang, Z., Wei, P., Gan, L., Li, W., Zeng, T., Qin, C., Chen, Z., & Liu, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11953 · Cited by 31
“HDAC2, a subtype of type I HDAC, is located in the nucleus and is primarily involved in inflam‐ matory inhibition (43,44).”
BackgroundGlucocorticoid receptor cofactors as therapeutic targets
Simons, S. S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.001 · Cited by 34
“FoxA1 [38] and HDAC2 [39] both increase the potency of www.sciencedirect.com GR-mediated gene induction.”
Corticosteroid Insensitivity in Smokers??with??Asthma: Clinical Evidence, Mechanisms, and Management
Thomson, N. C., Shepherd, M. C., Spears, M., & Chaudhuri, R. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605060-00010 · Cited by 36
Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity
Korkmaz, A., Öter, Ş., Seyrek, M., & Topal, T. (2009) · Interdisciplinary Toxicology · doi:10.2478/v10102-009-0020-4 · Cited by 36
Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications
Lisco, G., Giagulli, V. A., Pergola, G. D., Guastamacchia, E., Jirillo, E., Vitale, E., & Triggiani, V. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230803095118 · Cited by 35
Epigenetics and chromatin remodeling play a role in lung disease.
Mortaz, E., Masjedi, M. R., Barnes, P. J., & Adcock, I. M. (2011) · Europe PMC (PubMed Central) · Cited by 37
Self-citationGeneralized and tissue specific glucocorticoid resistance
Martins, C. S., & de Castro, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111277 · Cited by 32
ATF2 impairs glucocorticoid receptor–mediated transactivation in human CD8+ T cells
Li, L., Leung, D. Y. M., Strand, M. J., & Goleva, E. (2007) · Blood · doi:10.1182/blood-2007-01-070755 · Cited by 31
Li, Q., Wang, G., Xiong, S. H., Cao, Y., Liu, B., Sun, J., Li, L., Mohammadtursun, N., Yu, H., Dong, J., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113095 · Cited by 30
A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
Михайловна, Ж. Е., Lylova, E. S., Savinkova, A. V., Александрович, М. С., Игоревич, К. К., Belitsky, G. A., Геннадиевна, Я. М., & Lesovaya, E. A. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420974667 · Cited by 30
Glucocorticoid Receptor in Human Respiratory Epithelial Cells
Pujols, L., Mullol, J., & Picado, C. (2009) · NeuroImmunoModulation · doi:10.1159/000216187 · Cited by 31
Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy
Eom, G. H., & Kook, H. Y. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.3.242 · Cited by 29
“It has not been fully understood which enzymes are associated with the deacetylation process; however, several HDACs target non-histone proteins (23, 49-53).”
BackgroundSouza, N. H. C., Marcondes, P., Albertini, R., Mesquita‐Ferrari, R. A., Fernandes, K. P. S., & Aimbire, F. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.12.010 · Cited by 29
The Role of DNMT and HDACs in the Fetal Programming of Hypertension by Glucocorticoids
LaMothe, J. M., Khurana, S., Tharmalingam, S., Williamson, C., Byrne, C. J., Khaper, N., Mercier, S., & Tai, T. C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5751768 · Cited by 29
“GR is one such protein and can be deacetylated directly by HDACs (1, 2, and 3), altering how GR impacts transcription [10, 32].”
BackgroundMehra, M. R., KOBASHIGAWA, J. A., Deng, M. C.-H. K., Fang, K. C., Klingler, T. M., Lal, P. G., Rosenberg, S. J., Uber, P. A., Starling, R. C., Murali, S., et al. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.09.009 · Cited by 30
Biased regulation of glucocorticoid receptors signaling
Mao, L., Wei, W., & Chen, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115145 · Cited by 30
Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress
Mathews, H. L., Konley, T., Kosik, K. L., Krukowski, K., Eddy, J. L., Albuquerque, K., & Janusek, L. W. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.002 · Cited by 30
“This interaction inhibits CBP-associated histone acetyltransferase activity resulting in the active recruitment of histone deacetylase (Ito et al., 2000, 2006; Matthews et al., 2004; Tsaprouni et al., 2002; Espada and Esteller, 2007) and dephosphorylation complexes (Parra et al., 2007; Kim et al.,…”
BackgroundTargeting Lung Inflammation: Novel Therapies for the Treatment of COPD
Rahman, I., Yao, H., & de Boer, W. I. (2008) · Current Respiratory Medicine Reviews · doi:10.2174/157339808783497873 · Cited by 29
“Recent study showed that overexpression of HDAC2 in glucocorticoid-insensitive alveolar macrophages from patients with COPD is able to restore glucocorticoid sensitivity [72].”
BackgroundValproic acid prevents glucocorticoid‑induced osteonecrosis of the femoral head of rats
Zhou, D., Chen, Y., Yin, J., Tao, S., Guo, S., Wei, Z., Feng, Y., & Zhang, C. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3534 · Cited by 29
“In addition, the complex of dEX and GR recruits HdAc2 to the complex of nuclear factor-κB and activator protein 1 and reduces the associated inflammatory cytokine expression (70,71).”
BackgroundResultAcetylation of nuclear receptors in health and disease: an update
Ashton, A. W., Dhanjal, H. K., Rossner, B., Mahmood, H., Patel, V. I., Mohammad, N., Lota, M., Shahid, F., Li, Z., Joyce, D. A., et al. (2022) · FEBS Journal · doi:10.1111/febs.16695 · Cited by 27
“The GR undergoes ligand dependent acetylation [98] interacting with p300 and TAF-I b [104,105], and is acetylated by CLOCK, which repressed GR-induced transcription of several glucocorticoid-responsive genes [101,106].”
BackgroundCurrent thinking on genetics of chronic obstructive pulmonary disease
Molfino, N. A. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328013e97d · Cited by 27
Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer
Leehy, K. A., Anderson, T. M. R., Daniel, A. R., Lange, C. A., & Ostrander, J. H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0322 · Cited by 30
“This modification impairs the ability of GR to interfere with NF-κB signaling (Ito et al. 2006).”
BackgroundBuck, J. M., O’Neill, H. C., & Stitzel, J. A. (2020) · Epigenetics & Chromatin · doi:10.1186/s13072-020-00332-0 · Cited by 28
Jason, L. A., Sorenson, M., Sebally, K., Alkazemi, D. U. Z., Lerch, A., Porter, N. S., & Kubow, S. J. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.007 · Cited by 28
“These were chosen due to their influence on the NFjB pathway and interrelationship with glucocorticoid (Barnes, 2006; Ito et al., 2006).”
MethodAdcock, I. M., & Caramori, G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00031-6 · Cited by 26
Self-citationHu, L., Liu, F., Li, L., Zhang, L., Chen, Y., Li, Q., Qiu, J., Dong, J., Sun, J., & Zhang, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8702 · Cited by 25
“Therefore, primary GC resistance in patients with COPD may be attributed to the lack of HDAC2 in cells (19,79,80).”
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
Lin, D.-W., Chang, C., Hsu, Y., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073525 · Cited by 26
Kim, M., Kim, S., Kim, Y.-K., Hong, S., Min, K., Cho, S., & Park, H. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.6.708 · Cited by 25
“Because reduced HDAC2 expression was observed in bronchial biopsies of asthmatic patients [21] and HDAC2-mediated deacetylation of the corticosteroid receptor enabled nuclear factor-κB suppression in airway epithelial cell line and alveolar macrophages [22], the discussion of the corticosteroid response in asthma has…”
BackgroundDevereux, G. S., Cotton, S. C., Barnes, P. J., Briggs, A. H., Burns, G., Chaudhuri, R., Chrystyn, H., Davies, L., Soyza, A. D., Fielding, S., et al. (2015) · Trials · doi:10.1186/s13063-015-0782-2 · Cited by 25
“The use of ‘low dose’ theophylline derives from the demonstration by preclinical studies and two small randomised controlled trials that theophylline at ‘low dose’ (plasma concentration of 1–5 mg/l) increases the sensitivity of COPD airway inflammation to the anti-inflammatory effects of inhaled corticosteroids [15–22…”
Self-citationGlycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
Ngkelo, A., Hoffmann, R. F., Durham, A. L., Marwick, J. A., Brandenburg, S. M., de Bruin, H. G., Jonker, M. R., Rossios, C., Tsitsiou, E., Caramori, G., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00077.2015 · Cited by 28
Self-citationZhang, H., Liu, Q., Kong, L., & Xu, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.013 · Cited by 26
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice
Wang, D., Iclozan, C., Liu, C., Xia, C., Anasetti, C., & Yu, X. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.06.002 · Cited by 26
“HDAC2 activity is indispensible to control chronic obstructive pulmonary disease by corticosteroid [22,23].”
BackgroundTliba, O., & Amrani, Y. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200705-060vs · Cited by 28
“Interestingly, overexpression of a specific isoform of HDACs, HDAC2, in glucocorticoid-insensitive alveolar macrophages from patients with COPD was able to restore glucocorticoid sensitivity (74).”
BackgroundHuzard, D., Rappeneau, V., Meijer, O. C., Touma, C., Arango-Lievano, M., Garabedian, M. J., & Jeanneteau, F. D. (2020) · Stress · doi:10.1080/10253890.2020.1806226 · Cited by 24
“like nuclear factor kappa B (NF-κB) (Ito et al., 2006).”
BackgroundHow to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids
Strickland, B. A., Ansari, S. A., Dantoft, W., & Uhlenhaut, N. H. (2022) · FEBS Letters · doi:10.1002/1873-3468.14409 · Cited by 25
Moreira, J. D., Iakhiaev, A. V., Vankayalapati, R., Jung, B., & Samten, B. (2022) · iScience · doi:10.1016/j.isci.2022.104799 · Cited by 25
“Besides, reduced activity of HDAC2 is observed in alveolar macrophages isolated from patients with asthma or COPD, and the restoration of HDAC activity normalizes the cytokine responses of these macrophages in response to LPS (Cosio et al., 2004a, 2004b; Ito et al., 2006).”
BackgroundPelaia, G., Muzzio, C. C., Vatrella, A., Maselli, R., Magnoni, M. S., & Rizzi, A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1070826 · Cited by 24
“In vitro studies have shown that lung inflammation of COPD is resistant to ICS [10], possibly due to molecular mechanisms operating under conditions of oxidative stress, as reduced activity and expression of HDAC2 or increased phosphoinositol 3-kinase (PI3K) d signaling.”
BackgroundZhang, J., Feng, M., & Qu, J. (2012) · Mediators of Inflammation · doi:10.1155/2012/492901 · Cited by 24
“HDAC suppresses inflammatory gene expression and appears to be the key regulator in the development and procession of COPD [32, 33].”
BackgroundEpigenetic Aspects of Chronic Diseases
Roach, H. I., Oreffo, R. O. C., & Bronner, F. (2011) · Springer eBooks · doi:10.1007/978-1-84882-644-1 · Cited by 26
Adcock, I. M., Bhatt, S. P., Balkissoon, R., & Wise, R. A. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.09.006 · Cited by 24
Self-citationChen, X., Wang, D., Guo, X., Li, X., Ye, W., Yang, Q., & Gu, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.824652 · Cited by 25
“Curcumin modulates the histone acetylation and deacetylation process in the promoter region of the pro-inflammatory cytokine gene, leading to reversal of corticosteroid resistance in type II alveolar epithelial cells (Ito et al., 2006).”
BackgroundYim, R. P., & Koumbourlis, A. C. (2011) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2011.05.002 · Cited by 23
Kang, H., Kim, Y. S., & Ko, J. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0009 · Cited by 24
Guideline for the management of upper respiratory tract infections.
Brink, A. J., Cotton, M. F., Feldman, C. H., Geffen, L., Hendson, W., Hockman, M., Maartens, G., Madhi, S. A., Mutua-Mpungu, M., & Swingler, G. H. (2004) · PubMed · Cited by 27
Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
Marwick, J. A., & Chung, K. F. (2010) · International Journal of COPD · doi:10.2147/copd.s7390 · Cited by 24
“73,74,76 In vitro studies using small interfering RNA and overexpression models have shown that HDAC-2 is the key in the functional mechanism of GC-mediated or GR α -mediated histone deacetylation and gene repression.”
Class I Lysine Deacetylases Facilitate Glucocorticoid-induced Transcription
Kadiyala, V., Patrick, N. M., Mathieu, W., Jaime-Frias, R., Pookhao, N., An, L., & Smith, C. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505115 · Cited by 22
“GR acetylation has been shown to impair (42) or have no effect on DNA binding (43), suggesting that its impact may be gene-specific.”
BackgroundPin1 promotes GR transactivation by enhancing recruitment to target genes
Poolman, T. M., Farrow, S. N., Matthews, L. C., Loudon, A. S. I., & Ray, D. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt624 · Cited by 23
“In particular, acquired resistance to the action of GCs in inflammation is common, with a number of contributing factors proposed, including cross-talk from other proinflammatory signalling pathways, for example, mediated by TNF and interferon (35) or histone deacetylase enzymes (37,38).”
BackgroundHou, J., She, W., Du, X., Dai, Y., Xie, L., & Zhou, Q. (2015) · Otolaryngology · doi:10.1177/0194599815606911 · Cited by 24
Koopmans, T., Eilers, R. E., Menzen, M. H., Halayko, A. J., & Gosens, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01086 · Cited by 23
The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome
Zhao, X., Hwang, D., & Kao, H. (2018) · Nuclear Receptor Research · doi:10.11131/2018/101323 · Cited by 23
Nutrition, Epigenetic Mechanisms, and Human Disease
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449 · Cited by 83
Song, H., Tao, L., Chen, C., Pan, L., Hao, J., Ni, Y., Li, D., Li, B., & Shi, G. (2015) · PubMed · Cited by 23
Yonchuk, J. G., Foley, J. P., Bolognese, B. J., Logan, G., Wixted, W. E., Kou, J.-P., Chalupowicz, D. G., Feldser, H. G., Sanchez, Y., Nie, H., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241794 · Cited by 24
“…exposure (Guo et al., 2008), suppression of histone deacetylase 2 activity, which can amplify inflammatory responses (Osoata et al., 2009) and lead to corticosteroid resistance (Ito et al., 2006), and disruption of innate immune defenses associated with acute exacerbations (Berenson et al., 2006).”
BackgroundSun, X., Li, Q. Y., Gong, Y., Ren, L., Wan, H., & Deng, W.-W. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-079 · Cited by 21
“…clinical studies have confirmed that combination administration with theophylline is considered to be superior to ICS alone in terms of improvement in dyspnea and quality of life, and slows the decline in FEV1 in patients with COPD (Cosio et al. 2009; Kanehara et al. 2008; Zhou et al. 2006).”
BackgroundRandall, M. J., Haenen, G. R. M. M., Bouwman, F. G., van der Vliet, A., & Bast, A. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.10.009 · Cited by 22
“The observed thiol reactivity of acrolein combined with the presence of critical thiol groups on HDAC2 (Doyle and Fitzpatrick, 2010), a critical enzyme for the functionality of glucocorticoids (Ito et al., 2006), prompted us to identify whether acrolein directly adducts cysteine residues on HDAC2.”
BackgroundAnimal Models of Chronic Obstructive Pulmonary Disease Exacerbations: A Review of the Current Status
Oliveira, M. V. (2016) · Journal of Biomedical Sciencies · doi:10.4172/2254-609x.100022 · Cited by 22
Glucocorticoid Resistance in Inflammatory Diseases
Chrousos, G., & Franchimont, D. (2004) · CRC Press eBooks · doi:10.1201/9780203021941-39 · Cited by 21
Role of inflammasome in severe, steroid-resistant asthma
Khalil, B. A., Sharif‐Askari, N. S., & Halwani, R. (2023) · Current Research in Immunology · doi:10.1016/j.crimmu.2023.100061 · Cited by 21
Zhou, Y., Wang, G. F., Yang, L., Liu, F., Kang, J., Wang, R. L., Gu, W., & Wang, C. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154271 · Cited by 24
“Therefore, the suppression of NF-kB p65 expression and cytokine release in the lung could be due to increased expression of HDAC2 that inhibits NF-kBactivated gene expression (8,9).”
BackgroundResultInfluentialA ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function
Trebble, P., Woolven, J. M., Saunders, K. A., Simpson, K. D., Farrow, S. N., Matthews, L. C., & Ray, D. W. (2013) · Journal of Cell Science · doi:10.1242/jcs.124784 · Cited by 25
“In the nucleus GR binds to cis-elements to activate or repress target gene expression, recruiting co-modulator proteins from distinct classes to effect chromatin remodelling, and recruitment of the basal transcriptional machinery (Ford et al., 1997; Jones and Shi, 2003; Ito et al., 2006; Johnson et al., 2008).”
BackgroundMitchell, M. C., & Szabó, G. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch26 · Cited by 19
Packaging and Delivery of Asthma Therapeutics
Mathis, B. J., Kusumoto, M., Zaboronok, A., & Hiramatsu, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010092 · Cited by 20
Kim, M., Lee, H., Cho, H.-M., Kang, S., Lee, E., & Kim, I. K. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.1.23 · Cited by 20
“Acetylation of GR at the KTKK motif attenuates its repressive activity on NF-κB [33].”
BackgroundHua, H.-S., Wen, H.-C., Lee, H.-S., Weng, C., Yuliani, F. S., Kuo, H., Chen, B.-C., & Lin, C. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00931-5 · Cited by 18
“HDAC2 reduction plays a crucial role in glucocorticoid insensitivity by repressing NF-κB-mediated gene expression [25].”
BackgroundSato, T., Kotake, D., Hiratsuka, M., & Hirasawa, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059702 · Cited by 19
“Additionally, knockdown of HDAC2 by siRNA enhanced LPS-induced granulocyte macrophage-colony stimulating factor expression in epithelial cells and primary human lung macrophages [26].”
BackgroundGlucocorticoids: Molecular Mechanisms of Action
Cruz‐Topete, D., & Cidlowski, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_11 · Cited by 20
Negative regulation of transcription coactivator p300 by orphan receptor TR3
Li, G., Fang, J., Chen, H., Luo, J., Zheng, Z.-H., Shen, Y.-M., & Wu, Q. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm870 · Cited by 19
“They function in these pathways by acetylating multiple target proteins, including transcription factors such as p53 (4), NF-kB (5) and b-catenin (6), and nuclear receptors such as ER (7), AR (8) and GR (9).”
BackgroundLiu, Y., McGarry, S. V., Cruickshank, D., & Jensen, G. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291254 · Cited by 17
Zhang, X., Chen, J., Gao, Z., Qi, H., Dai, Y., & She, W. (2019) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2018.01298 · Cited by 17
“This model is supported by observations that histone deacetylases are recruited by GRs for transrepression [14].”
Haghi, M., Hittinger, M., Zeng, Q., Oliver, B. G. G., Traini, D., Young, P. M., Huwer, H., Schneider‐Daum, N., & Lehr, C. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00124 · Cited by 17
Ueda, K., Nishimoto, Y., Kimura, G., Masuko, T., Barnes, P. J., Ito, K., & Kizawa, Y. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.07.020 · Cited by 19
Self-citationKadowaki, M., Yamada, H., Sato, K., Shigemi, H., Umeda, Y., Morikawa, M., Waseda, Y., Anzai, M., Kamide, Y., Aoki‐Saito, H., et al. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0207-1 · Cited by 17
Weng, J., Wang, Y., & Sun, T. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000107 · Cited by 17
Dubey, S., Khan, J., Alishlash, A. S., & Matalon, S. (2026) · Physiological Reviews · doi:10.1152/physrev.00038.2025 · Cited by 17
Cave, A. C., & Hurst, M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.008 · Cited by 18
Analgesic and anti-inflammatory activity of 7-substituted purine-2,6-diones
Zygmunt, M., Chłoń‐Rzepa, G., & Sapa, J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.06.015 · Cited by 16
“e molecular mechanism of the anti-inflammatory effect of eophylline implicate the inhibition of PDE4 and histone acetylase-2 activation, resulting in switching off the activated flammatory genes [6–9].”
BackgroundNi, W., Lin, N., He, H., Zhu, J., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091083 · Cited by 17
“HDACs have the ability to deacetylate non-histone proteins such as nuclear factor kB (NF-kB) which play a critical role in inflammatory signaling pathways [15].”
BackgroundDevereux, G. S., Cotton, S. C., Fielding, S., McMeekin, N., Barnes, P. J., Briggs, A., Burns, G., Chaudhuri, R., Chrystyn, H., Davies, L., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23370 · Cited by 16
Self-citationDietary Advanced Glycation Endproducts Decrease Glucocorticoid Sensitivity In Vitro
van der Lugt, T., Weseler, A. R., Vrolijk, M. F., Opperhuizen, A., & Bast, A. (2020) · Nutrients · doi:10.3390/nu12020441 · Cited by 17
Nawrocki, M. J., Strugała, A., Piotrowski, P., Wudarski, M., Olesińska, M., & Jagodziński, P. P. (2015) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-015-1619-9 · Cited by 16
Salam, M. T. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8603-9_11 · Cited by 18
Zhu, P., Zheng, W., Auld, D. S., Jadhav, A., MacArthur, R., Olson, K. R., Peng, K., Dotimas, H., Austin, C. P., & Inglese, J. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708785204045 · Cited by 16
Revealing the clinical effect and biological mechanism of acupuncture in COPD: A review
Shi, F., Cao, J., Zhou, D., Wang, X., Yang, H., Liu, T., Chen, Z., Zeng, J., Du, S., Yang, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115926 · Cited by 15
Hentati-Kallel, M., Jan, S. L., Bernard, P., Antonicelli, F. D., & Trussardi‐Régnier, A. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3830 · Cited by 15
Singh, H., Agarwal, V., Chaturvedi, S., Misra, D. P., Jaiswal, A. K., & Prasad, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00558 · Cited by 15
“…activation of pro-inflammatory genes by recruiting histone deacetylase 2 (HDAC2) (Ito et al., 2000), a reduction in HDAC2 expression and activity had been linked with increased inflammation in chronic obstructive pulmonary disease (COPD) and bronchial asthma patients (Ito et al., 2002, 2005, 2006).”
BackgroundPosttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
Gadasheva, Y., Nolze, A., & Großmann, C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.667990 · Cited by 15
“GR deacetylation in this region facilitates NF-κB suppression (Ito et al., 2006) and regulates the expression of genes involved in generating circadian rhythm (Nader et al.”
BackgroundOvercoming steroid unresponsiveness in airways disease
Adcock, I. M., Chou, P.-C., Durham, A. L., & Ford, P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370824 · Cited by 15
Self-citationNovel insights into the neuroendocrine control of inflammation: the role of GR and PARP1
Aprile-Garcia, F., Antunica-Noguerol, M., Budziñski, M. L., Liberman, A. C., & ARZT, E. S. (2013) · Endocrine Connections · doi:10.1530/ec-13-0079 · Cited by 16
Modulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
Liberman, A. C., Antunica-Noguerol, M., & ARZT, E. S. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101086 · Cited by 18
“As will be further discussed, HDAC also directly targets GR and Hsp90 regulating its activity [88, 90].”
InfluentialTherapeutic targets for new therapy for corticosteroid refractory asthma
Ito, K., & Mercado, N. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903078431 · Cited by 17
“This nuclear receptor (NR) acetylation site is conserved amongst related NRs [25] and we confirmed that lysines 494 and 495 within the DNA binding domain/hinge region of GR were the target of acetylation by mutagenesis study [26].”
BackgroundSelf-citationSteroids and histone deacetylase in ventilation-induced gene transcription
Dombrowsky, H., & Uhlig, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00134006 · Cited by 15
Borin, C., Pieters, T., Serafin, V., & Ntziachristos, P. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000916 · Cited by 14
Increased Metallothionein Expression Reflects Steroid Resistance in Renal Allograft Recipients
Rekers, N. V., Bajema, I. M., Mallat, M. J. K., Anholts, J. D. H., de Vaal, Y. J. H., Zandbergen, M., Haasnoot, G. W., van Zwet, E. W., de Fijter, J. W., Claas, F. H. J., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12314 · Cited by 14
Douma, T. N., Millan, M. J., Verdouw, P. M., Oosting, R. S., Olivier, B., & Groenink, L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.032 · Cited by 16
“In human lung cells, it has been shown that acetylated GR receptors trans-activate gene expression, while deacetylated GR receptors inhibit gene expression via trans-repression (e.g. via binding to NFkB) (Ito et al., 2006).”
BackgroundWang, J., Liu, H., Gao, L., & Liu, X. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00109 · Cited by 14
“HDACs regulate chromatin compaction, and aberrant HDAC expression and activity leads to defective lung development, and has been associated with the severity of COPD disease [38, 39] Currently, little is known about how doxorubicin affects the epigenetic control”
BackgroundComparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients
Essilfie-Quaye, S., Ito, K., Ito, M., Kharitonov, S. A., & Barnes, P. J. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.020 · Cited by 16
Self-citationGlucocorticoids: The mode of action in bullous pemphigoid
Kubin, M. E., Hellberg, L., & Palatsi, R. (2017) · Experimental Dermatology · doi:10.1111/exd.13408 · Cited by 16
Metadata
- Authors
- Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M.
- Affiliations
- Imperial College London (GB)
- Airway Disease Section, National Heart and Lung Institute, Imperial College, London SW3 6LY, England, UK
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-12-27
- Volume
- 203
- Issue
- 1
- Pages
- 7-13
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118081
- OpenAlex
- W2131160124
- Cited by
- 638
- References
- 28
- Citations by year
- 2026: 20 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 31 · 2018: 18 · 2017: 29 · 2016: 36 · 2015: 36 · 2014: 45 · 2013: 50 · 2012: 39
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- GlaxoSmithKline
- European Respiratory Society
- British Lung Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- HDAC2, glucocorticoid receptor, glucocorticoid resistance, NF-κB, chronic obstructive pulmonary disease, alveolar macrophages, dexamethasone, IL-1β, GM-CSF, glucocorticoid response element, transcriptional repression
- MeSH terms
- Cells, Cultured, Dexamethasone, Histone Deacetylases, Humans, Interleukin-1, Receptors, Glucocorticoid, Repressor Proteins, Transfection, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Granulocyte-Macrophage Colony-Stimulating Factor, NF-kappa B, Macrophages, Alveolar, Pulmonary Disease, Chronic Obstructive, RNA, Small Interfering, Cell Line, Tumor, Histone Deacetylase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.